K2X Capital appoints key executives to strengthen capital markets strategy and deliver next phase of institutional growth.
K2X Technology & Life Science, Inc. K2X Capital, a pioneering investment platform transforming global access to early-stage technology and life science innovation, announced the expansion of its executive leadership team. These key appointments are designed to accelerate K2X Capital’s continued growth, global impact, and ability to create value for its investor community.
Executive leadership appointments include:
ZACH NOLING, Chief Financial Officer
- Zach Noling is an accomplished finance executive known for guiding organizations through dynamic growth phases. Having recently led pre-IPO to post-IPO readiness for a successful life sciences company NASDAQ IPO, Zach offers deep expertise that spans capital formation, financial operations, and regulatory compliance. Zach’s background — from startup advisory to leadership in scaling finance organizations — ensures K2X Capital maintains disciplined strategy during a period of significant expansion.
Read More on Fintech : Global Fintech Interview with Kevin Wall, Chief Financial Officer at Stax
TONYA J. LONG, Chief Investor Officer
- Tonya J. Long is a strategic operator, having led 400 product launches, 20 M&A integrations, and international expansion initiatives. A recognized industry thought leader, community builder, and bestselling author/speaker regarding artificial intelligence, Tonya guides boards on AI strategy and transformation. She’s responsible for K2X’s investor strategy, stakeholder engagement, and operational excellence supporting our strategic growth plans.
CLARK CALLANDER, Board Member
- Clark Callander is a seasoned entrepreneur and advisor with deep experience across governance, growth strategy, and transaction leadership. As a board member, Clark strengthens K2X Capital’s strategic oversight and supports sustainable growth initiatives across markets.
Transforming the Investment Landscape
“These appointments mark an exciting milestone for K2X Capital as we enter our next stage of growth and industry impact,” said Paul M. Russo, PhD, Chairman and CEO of K2X Technology & Life Science, Inc. “Zach, Tonya, and Clark bring the sophistication and executional strength needed for high-stakes capital stewardship. They understand how to navigate institutional markets, scale trust with investors, and architect long-term value creation.”
K2X Capital oversees a diversified portfolio of more than 90 early-stage companies spanning the United States, Canada, Israel, and India. Through a rigorous double-vetting due diligence protocol and deep pool of 100+ veteran advisors (all of whom are investors in the fund), K2X Capital is setting new standards in investor access and portfolio strategy as we create “The ETF of Startups”!
Catch more Fintech Insights : The Impact of Open Banking on Cross-Carrier Data Sharing in Insurance
[To share your insights with us, please write to psen@itechseries.com ]
